News - Wyeth
WebMD Appoints Pharmaceutical And Consumer Healthcare Industry Innovator Cavan M. Redmond As New CEO
2012-06-01 02:23:45
NEW YORK, June 1, 2012 /PRNewswire/ -- WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, announced today that Cavan M.
2012-05-11 23:00:34
In the briefing documents for the May 10th, 2012 meeting of the FDA Advisory Committee, reviewers expressed concerns on safety of Lorcaserin obesity drug.
2012-04-23 10:23:24
FAIRFIELD Conn., April 23, 2012 /PRNewswire/ -- Ury & Moskow and Bubalo Rotman secured a $4 million verdict plus punitive damages against Wyeth Inc., on behalf of their client who developed
2012-04-19 23:00:55
On March 29th, 2012, an FDA Advisory Panel recommended further clinical trials for weight-loss drugs to better assess heart risks.
